-
1
-
-
4243262227
-
Clinical phase I experience with INGN 201 (Ad-p53) in non-small cell lung cancer and head and neck cancer
-
(Abstr.)
-
(1997)
Cancer Gene Ther
, vol.4
-
-
Merritt, J.1
-
2
-
-
0001458965
-
Three phase II trials of intratumoral injection with a replication-deficient adenovirus carrying the p53 gene (AdCMV-p53) in patients with recurrent/refractory head and neck cancer
-
(1999)
Proc Am Soc Clin Oncol
, vol.18
, pp. 1661
-
-
Nemunaitis, J.1
-
3
-
-
0034128881
-
Replication-selective micro-organisms: Fighting cancer with targeted germ warfare
-
(2000)
J Clin Invest
, vol.105
, pp. 836-838
-
-
Kirn, D.1
-
6
-
-
0033152894
-
Intravenous administration of ONYX-015, a selectively-replicating adenovirus, induces antitumoral efficacy
-
(1999)
Cancer Res
, vol.59
, pp. 2623-2628
-
-
Heise, C.1
-
7
-
-
0001481110
-
Selectively-replicating viruses as therapeutic agents against cancer
-
Gerschenson LA (ed.) Academic Press: San Diego
-
(1998)
Cancer Gene Therapy
, vol.1
, pp. 235-248
-
-
Kirn, D.1
-
8
-
-
77049281450
-
Studies on the use of viruses in the treatment of carcinoma of the cervix
-
(1956)
Cancer
, vol.9
, pp. 1211-1218
-
-
Smith, R.1
-
10
-
-
0016358317
-
Treatment of human cancer with mumps virus
-
(1974)
Cancer
, vol.34
, pp. 1907-1928
-
-
Asada, T.1
-
11
-
-
0025864440
-
Experimental therapy of human glioma by means of a genetically engineered virus mutant
-
(1991)
Science
, vol.252
, pp. 854-856
-
-
Martuza, R.L.1
-
13
-
-
0029023868
-
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas
-
(1995)
Nat Med
, vol.1
, pp. 938-943
-
-
Mineta, T.1
-
14
-
-
0344188096
-
An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
-
(see comments)
-
(1996)
Science
, vol.274
, pp. 373-376
-
-
Bischoff, J.R.1
-
15
-
-
0030917202
-
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
-
(see comments)
-
(1997)
Nat Med
, vol.3
, pp. 639-645
-
-
Heise, C.1
-
16
-
-
0028081158
-
Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy
-
(1994)
Cancer Res
, vol.54
, pp. 6017-6021
-
-
Lorence, R.M.1
-
17
-
-
0027377254
-
Parvovirus H-1 inhibits growth of short-term tumor-derived but not normal mammary tissue cultures
-
(1993)
Int J Cancer
, vol.55
, pp. 672-677
-
-
Van Pachterbeke, C.1
-
21
-
-
0033929057
-
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
-
(2000)
Nat Med
, vol.6
, pp. 821-825
-
-
Stojdl, D.F.1
-
23
-
-
0029871369
-
The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model
-
(1996)
J Virol
, vol.70
, pp. 2431-2439
-
-
Sparer, T.E.1
-
24
-
-
0030790684
-
Prostate attenuated replication competent adenovirus (ARCA) CN706: A selective cytotoxic for prostate-specific antigen-positive prostate cancer cells
-
(1997)
Cancer Res
, vol.57
, pp. 2559-2563
-
-
Rodriguez, R.1
-
26
-
-
0025864440
-
Experimental therapy of human glioma by means of a genetically engineered virus mutant
-
(1991)
Science
, vol.252
, pp. 854-856
-
-
Martuza, R.L.1
-
27
-
-
0029023868
-
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas
-
(1995)
Nat Med
, vol.1
, pp. 938-943
-
-
Mineta, T.1
-
31
-
-
0033022039
-
p53-independent and -dependent requirements for E1B-55kD in adenovirus type 5 replication
-
(1999)
J Virol
, vol.73
, pp. 5333-5344
-
-
Harada, J.1
Berk, A.2
-
32
-
-
0001673477
-
Hepatic arterial infusion of a replication-selective adenovirus, Onyx-015: A phase I/II clinical trial
-
(Abstr.)
-
(2000)
Proc Am Soc Clin Oncol
, vol.19
, pp. 953
-
-
Reid, T.1
-
33
-
-
0033619892
-
Hepatic arterial infusion of chemotherapy following resection of hepatic metastases from colorectal cancer
-
(1999)
N Engl J Med
, vol.341
, pp. 2039-2048
-
-
Kemeny, N.1
-
34
-
-
12944328660
-
A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer
-
(2000)
Clin Cancer Res
, vol.6
, pp. 798-806
-
-
Ganly, I.1
-
35
-
-
0001374549
-
A phase I study of multiple direct injections of ONYX-015 adenovirus under endoscopic ultrasound guidance
-
(Abstr.)
-
(1999)
Proc Am Soc Clin Oncol
, vol.18
, pp. 186
-
-
Hecht, J.R.1
-
36
-
-
0001673475
-
Endoscopic ultrasound-guided intratumoral injection of pancreatic carcinomas with a replication-selective adenovirus: A phase I/II clinical trial
-
(Abstr.)
-
(2000)
Proc Am Soc Clin Oncol
, vol.19
, pp. 1039
-
-
Hecht, R.1
-
37
-
-
0000469809
-
A phase II trial of ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
-
(Abstr.)
-
(1999)
Proc Am Soc Clin Oncol
, vol.18
, pp. 1505
-
-
Kirn, D.H.1
-
38
-
-
0000957066
-
A phase I trial of an E1B-55kD gene-deleted adenovirus administered by intraperitoneal injection into patients with advanced, refractory ovarian carcinoma
-
(Abstr.)
-
(2000)
Proc Am Soc Clin Oncol
, vol.19
, pp. 1512
-
-
Vasey, P.1
-
40
-
-
0033831080
-
A controlled trial of Onyx-015, an E1B gene-deleted adenovirus, in combination with chemotherapy in patients with recurrent head and neck cancer
-
(2000)
Nat Med
, vol.6
, pp. 879-885
-
-
Khuri, F.1
-
41
-
-
0004086627
-
A phase I/II trial of ONYX-015 administered by hepatic artery infusion to patients with colorectal carcinoma
-
EORTC-NCI-AACR Meeting on Molecular Therapeutics of Cancer
-
(1999)
-
-
Reid, A.1
-
42
-
-
0000173252
-
A phase II trial of intratumoral injection with an E1B-deleted adenovirus, ONYX-015, in patients with recurrent, refractory head and neck cancer
-
(1998)
Proc Am Soc Clin Oncol
, vol.17
-
-
Kirn, D.1
-
43
-
-
0030917202
-
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
-
(see comments)
-
(1997)
Nat Med
, vol.3
, pp. 639-645
-
-
Heise, C.1
-
44
-
-
0033831080
-
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
-
(see comments)
-
(2000)
Nat Med
, vol.6
, pp. 879-885
-
-
Khuri, F.R.1
-
46
-
-
0031743945
-
Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells
-
(1998)
J Virol
, vol.72
, pp. 9470-9478
-
-
Rothmann, T.1
-
49
-
-
0031060333
-
The early region 1B 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle
-
(1997)
J Virol
, vol.71
, pp. 548-561
-
-
Goodrum, F.D.1
Ornelles, D.A.2
-
50
-
-
0033782862
-
An E1A mutant adenovirus with potent and selective systemic antitumoral efficacy
-
(2000)
Nat Med
, vol.6
, pp. 1134-1139
-
-
Heise, C.1
-
51
-
-
0023099280
-
Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection
-
(1987)
Virology
, vol.156
, pp. 107-121
-
-
Barker, D.D.1
Berk, A.J.2
-
52
-
-
0030753963
-
Nuclear export of the E1B 55-kDa and E4 34-kDa adenoviral oncoproteins mediated by a rev-like signal sequence
-
(1997)
EMBO J
, vol.16
, pp. 4276-4284
-
-
Dobbelstein, M.1
-
55
-
-
0034610723
-
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
-
(2000)
Oncogene
, vol.19
, pp. 2-12
-
-
Fueyo, J.1
-
57
-
-
0032503659
-
A novel three-pronged approach to kill cancer cells selectively: Concomitant viral, double suicide gene, and radiotherapy
-
(see comments)
-
(1998)
Hum Gene Ther
, vol.9
, pp. 1323-1333
-
-
Freytag, S.O.1
-
59
-
-
0028034286
-
Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene
-
(1994)
Cancer Res
, vol.54
, pp. 5745-5751
-
-
Boviatsis, E.J.1
-
60
-
-
13044300857
-
Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae
-
(1999)
Science
, vol.286
, pp. 1568-1571
-
-
Roelvink, P.1
-
62
-
-
0032927753
-
Lipid A mutant salmonella with suppressed virulence and TNF-alpha induction retain tumor-targeting in vivo
-
(1999)
Nat Biotechnol
, vol.17
, pp. 37-41
-
-
Low, K.1
-
63
-
-
0033693231
-
Selective replication and oncolysis in p53 mutant tumors with Onyx-015, an E1B-55kD gene-deleted adenovirus, in patients with head and neck cancer
-
(2000)
Cancer Res
, vol.60
, pp. 6359-6366
-
-
Nemunaitis, J.1
-
64
-
-
0006188214
-
Combination therapy with a replication-selective adenovirus and cisplatin chemotherapy; dependence on sequencing but independence from p53 gene status or route of administration
-
(in press)
-
Clin Cancer Res
-
-
Heisse, C.1
Kirn, D.2
-
65
-
-
0033623250
-
Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (Onyx-015)
-
(2000)
Nature Med
, vol.6
, pp. 1128-1133
-
-
Ries, S.1
|